ImmunoPrecise Antibodies (IPA) to Release Quarterly Earnings on Friday

ImmunoPrecise Antibodies (NASDAQ:IPA) is expected to be announcing its earnings results before the market opens on Friday, March 28th. Analysts expect the company to announce earnings of ($0.06) per share and revenue of $6.59 million for the quarter. Parties interested in participating in the company’s conference call can do so using this link.

ImmunoPrecise Antibodies Stock Up 1.5 %

Shares of NASDAQ IPA opened at $0.45 on Friday. ImmunoPrecise Antibodies has a 12-month low of $0.27 and a 12-month high of $1.64. The company has a market cap of $13.87 million, a P/E ratio of -0.57 and a beta of 0.09. The company has a current ratio of 1.01, a quick ratio of 0.85 and a debt-to-equity ratio of 0.36. The stock has a fifty day moving average price of $0.45 and a 200 day moving average price of $0.49.

Analyst Ratings Changes

Separately, HC Wainwright reissued a “buy” rating and issued a $7.00 price objective on shares of ImmunoPrecise Antibodies in a research report on Friday, March 14th.

About ImmunoPrecise Antibodies

ImmunoPrecise Antibodies Ltd., together with its subsidiaries, operates as a biotherapeutic research and technology company in Canada and internationally. It provides NonaVac DNA for complex protein classes, including GPCRs and ion channels; and Rapid Prime, a positive monoclonal antibodies for generating anti-idiotypic antibodies, and producing monoclonal antibodies against conformational epitopes.